Viking Therapeutics
0 followers
VKTX
Performance
About Viking Therapeutics
Viking Therapeutics is a biotechnology company focused on developing novel therapeutics for metabolic and endocrine disorders. Its pipeline includes targeted therapies for obesity, nonalcoholic fatty liver disease (NASH), rare diseases like X-ALD, and other conditions affecting metabolism and energy homeostasis, with multiple programs such as VK2735, VK2809, VK0214, VK5211, VK0612, VK1430, and EPOR agonist programs. The company aims to address unmet medical needs in metabolic diseases and related metabolic/endocrine disorders, with development efforts likely centered in the United States.
Recent News
Recent Deals
No recent deals for this company.